HCAT
|
Health Catalyst, Inc.
|
1.02%
|
US
|
NASDAQ
|
HOLX
|
Hologic, Inc.
|
1.01%
|
US
|
NASDAQ
|
BLUE
|
bluebird bio, Inc.
|
1.01%
|
US
|
NASDAQ
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
1.01%
|
US
|
NASDAQ
|
1066
|
Shandong Weigao Group Medical Polymer Co Ltd
|
1.01%
|
HK
|
HK
|
SOON
|
Sonova H Ag
|
1.00%
|
CH
|
SW
|
CRBU
|
Caribou Biosciences, Inc.
|
1.00%
|
US
|
NASDAQ
|
WST
|
West Pharmaceutical Services, Inc.
|
1.00%
|
US
|
NYSE
|
SN
|
Smith & Nephew
|
1.00%
|
UK
|
LSE
|
A
|
Agilent Technologies, Inc.
|
1.00%
|
US
|
NYSE
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
0.99%
|
US
|
NASDAQ
|
TDOC
|
Teladoc, Inc.
|
0.98%
|
US
|
NYSE
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.98%
|
US
|
NASDAQ
|
ILMN
|
Illumina, Inc.
|
0.98%
|
US
|
NASDAQ
|
CRSP
|
CRISPR Therapeutics AG
|
0.98%
|
US
|
NASDAQ
|
ALKS
|
Alkermes plc
|
0.98%
|
US
|
NASDAQ
|
MDT
|
Medtronic Inc.
|
0.98%
|
US
|
NYSE
|
COH
|
Cochlear Limited
|
0.98%
|
AU
|
ASX
|
EW
|
Edwards Lifesciences Corporation
|
0.98%
|
US
|
NYSE
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
0.97%
|
US
|
NASDAQ
|